Variant ID | 27833 |
---|---|
Entrez Gene ID | 112399 |
Gene | EGLN3 (GeneCards) |
Location | hg19 14:34530036-34530036
hg38 14:34060830-34060830 |
Disease | Asymptomatic |
Method | Single cell Sequencing Cell cloning |
Mutation(HGVS format) | NC_000014.8:g.34530036 C>T (Genome Assembly: GRCh37) |
Exon or Intron | NA |
---|---|
Position in protein | NA |
Amino acid changes in protein | NA > NA |
Position in cDNA | NA |
Changes in cDNA | NA > NA |
mRNA accession | NA |
mRNA length | NA |
Reference length | 107349540 |
MAF in gnomAD genome (version 2.0.1) | 0.0006 |
---|---|
EIGEN score | 0.3969 |
CADD Raw score (version 1.3) | 0.677121 (Deleterious) |
FATHMM raw prediction score | 0.27872 (Tolerated) |
Deleterious probability by DeFine | 0.7521 (Deleterious) |
Entrez Gene ID | 112399 (NCBI Gene) |
---|---|
Official Gene Symbol | EGLN3 (GeneCards) |
Number of variants in EGLN3 in this database | 10 (view all the variants) |
Full name | egl-9 family hypoxia inducible factor 3 |
Band | 14q13.1 |
Other IDs | Vega: OTTHUMG00000029498 OMIM: 606426 HGNC: HGNC:14661 Ensembl: ENSG00000129521 |
Other names | PHD3, HIFPH3, HIFP4H3 |
Summary | None |
Individual ID | 29217587.02 (view all the variants in this individual) |
---|---|
Pubmed ID | 29217587 |
Whose mosaic mutation | Normal |
Phenotype | 1 |
Disease | Asymptomatic |
OMIM ID |